(19)
(11) EP 1 047 425 A1

(12)

(43) Date of publication:
02.11.2000 Bulletin 2000/44

(21) Application number: 98962096.8

(22) Date of filing: 14.12.1998
(51) International Patent Classification (IPC)7A61K 31/435, A61K 31/40, C07D 207/26, C07D 413/06, C07D 471/04, C07D 401/06
(86) International application number:
PCT/US9826/539
(87) International publication number:
WO 9930/709 (24.06.1999 Gazette 1999/25)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.12.1997 US 69910 P
27.04.1998 US 83251 P
13.05.1998 GB 9810182
26.05.1998 GB 9811283
13.07.1998 US 92588 P

(71) Applicant: MERCK & CO., INC.
Rahway, New Jersey 07065 (US)

(72) Inventors:
  • DUGGAN, Mark, E.
    Rahway, NJ 07065 (US)
  • MEISSNER, Robert, S.
    Rahway, NJ 07065 (US)
  • PERKINS, James, J.
    Rahway, NJ 07065 (US)

(74) Representative: Thompson, John Dr. et al
Merck & Co., Inc.European Patent DepartmentTerlings ParkEastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) INTEGRIN RECEPTOR ANTAGONISTS